Peptides Before and After: Realistic Results and Timelines by Peptide Type

Peptide before-and-after results depend on the peptide, goal, dose studied, and medical fit. Semaglutide and tirzepatide have the strongest weight-loss data, with visible changes often emerging over 8–12 weeks and larger trial results measured over 36–72 weeks. Sermorelin, NAD+, and glutathione usually have slower, less visual outcomes.

What are peptides, and what does before and after really mean?

Peptides are short chains of amino acids that can act like signals in the body. A “before and after” may mean less hunger, lower weight, better waist measurement, improved sleep, clearer skin tone, better workout recovery, or improved lab markers—but each peptide category has different evidence and different risks.

Peptides vs. small-molecule drugs

Small-molecule drugs are usually tiny chemicals that can be made into pills. Peptides are larger and often break down in the stomach, which is why many are given by injection or nasal spray. Semaglutide, tirzepatide, and sermorelin are peptides or peptide-like medicines that work through hormone signaling pathways 1, 2, 5.

For weight loss, the strongest evidence is for the active ingredients semaglutide and tirzepatide as studied in large trials and FDA-approved brand labels. Wegovy (semaglutide, a GLP-1 receptor agonist; also available as a compounded formulation through licensed 503A pharmacies) and Ozempic (semaglutide, FDA-approved for type 2 diabetes) share the same active ingredient but have different labeled uses and dose schedules 1, 6.

Zepbound (tirzepatide, a GLP-1/GIP dual agonist; also available as a compounded formulation through licensed 503A pharmacies) and Mounjaro (tirzepatide, FDA-approved for type 2 diabetes) also share an active ingredient but have different labeled uses 2, 7. Compounded formulations are not FDA-approved and should not be described as the same as, generic versions of, or equivalent to these brands.

Why results are gradual, not overnight

Most peptide results are indirect. A GLP-1 may reduce appetite and help people stay in a calorie deficit. Sermorelin signals the pituitary gland to release growth hormone, which can affect body composition over time. NAD+ and glutathione relate more to cellular metabolism and oxidative stress than fast visual change 5, 8, 9.

How long does it take to see results from peptide therapy?

Peptide therapy timelines are usually measured in weeks to months. Weight-loss peptides can change appetite within early weeks, but visible body changes often take 8–12 weeks and depend on nutrition, dose studied, side effects, and consistency.

Weeks 1–4: early signals

In GLP-1 treatment, early changes are often appetite-related: feeling full sooner, fewer cravings, or smaller meals. These effects are consistent with the known GLP-1 mechanism of slowing gastric emptying and signaling satiety in the brain 1, 6. Side effects can also appear early, especially nausea, vomiting, diarrhea, constipation, reflux, and abdominal discomfort 1, 2.

Weeks 4–12: visible changes

By weeks 4–12, some people see changes in weight, waist fit, and meal size. But this is also the period when side effects or poor protein intake can slow progress. In the STEP and SURMOUNT programs, the largest reported changes came after many months, not after a single month 3, 4.

Months 3–6: full results start to take shape

For body composition, the 3–6 month window is often more meaningful than the first few weeks. Resistance training, enough protein, sleep, and dose tolerance all matter because weight loss can include lean mass as well as fat mass 10. For sermorelin, any change is also gradual because the pathway depends on pituitary signaling and downstream growth-hormone biology 5.

What before-and-after results can you expect by peptide type?

Peptide before-and-after results are not one category. GLP-1s are mainly weight-loss and metabolic medicines; sermorelin is a growth-hormone-releasing hormone analog; NAD+ and glutathione are cellular-support compounds with less direct visual transformation data.

Semaglutide weight-loss results

Semaglutide (INN) is a GLP-1 receptor agonist. The FDA-approved Wegovy label lists a starting dose of 0.25 mg once weekly for 4 weeks, followed by stepwise escalation to maintenance doses of 1.7 mg or 2.4 mg once weekly; this is label information, not personal dosing advice 1.

In STEP 1, adults with overweight or obesity without diabetes received semaglutide 2.4 mg once weekly plus lifestyle intervention. Mean body weight fell 14.9% at 68 weeks with semaglutide versus 2.4% with placebo; individual results vary 3. Common risks include nausea, diarrhea, vomiting, constipation, abdominal pain, gallbladder disease, and rare pancreatitis warnings on the label 1.

At Chia, compounded semaglutide injection is available through a licensed-provider evaluation, with microdosing plans available when clinically appropriate. Plans currently start at $249/mo. Compounded semaglutide is not FDA-approved and has no FDA-evaluated outcomes data.

Tirzepatide weight-loss results

Tirzepatide (INN) is a GLP-1/GIP dual agonist. The FDA-approved Zepbound label describes once-weekly subcutaneous dosing with dose escalation; labeled maintenance doses include 5 mg, 10 mg, and 15 mg once weekly 2.

In SURMOUNT-1, adults with obesity or overweight plus at least one weight-related condition received tirzepatide 5 mg, 10 mg, or 15 mg once weekly. Mean weight reductions at 72 weeks were 15.0%, 19.5%, and 20.9%, compared with 3.1% for placebo; individual results vary 4. Common side effects include nausea, diarrhea, constipation, vomiting, abdominal pain, dyspepsia, injection-site reactions, and warnings for gallbladder disease and pancreatitis 2.

At Chia, compounded tirzepatide tablets and injection are available after clinician review, with microdosing plans available when appropriate. Plans currently start at $249/mo for tablets and $299/mo for injections. Compounded tirzepatide is not FDA-approved and has no FDA-evaluated outcomes data.

Sermorelin and growth-hormone-releasing peptides

Sermorelin (INN) is a growth hormone-releasing hormone analog. It signals the pituitary gland to release growth hormone, rather than directly replacing growth hormone 5. Human data are more limited than GLP-1 data, so before-and-after expectations should be slower and more modest.

In clinical research, sermorelin has been studied for growth-hormone physiology and diagnostic uses, with changes in growth-hormone secretion rather than large cosmetic before-and-after outcomes 5. Possible side effects include injection-site reactions, flushing, headache, dizziness, nausea, and changes in glucose handling in susceptible patients 5. People with active cancer, certain pituitary problems, or uncontrolled metabolic disease need careful medical review.

At Chia, compounded sermorelin is available as injection, nasal spray, and tablets after provider review. It can also be part of the GLP-1 + Sermorelin protocol for patients whose clinician agrees that both weight and body-composition goals are medically appropriate.

NAD+ for energy and cellular aging

NAD+ means nicotinamide adenine dinucleotide, a molecule involved in energy metabolism, DNA repair signaling, and redox balance. NAD+ levels and NAD-related pathways have been studied in aging biology, but human before-and-after outcomes are not as clear or visual as GLP-1 weight-loss data 8, 11.

Human trials of NAD+ precursors such as nicotinamide riboside show that blood NAD-related metabolites can rise, but outcomes like energy, exercise performance, or aging changes vary by study and are not guaranteed 11. Side effects can include nausea, flushing, headache, fatigue, or injection-related discomfort depending on form and patient factors.

At Chia, NAD+ is available as injection from $199/mo and nasal spray from $129/mo after licensed-provider review. NAD+ injection is also included in the Foundation Longevity protocol, which pairs sermorelin injection, NAD+ injection, and glutathione injection.

Glutathione for skin and oxidative stress

Glutathione is a major antioxidant made by the body. It helps maintain redox balance and supports detoxification pathways, but “glutathione before and after” claims online often overstate the evidence 9.

In a randomized trial, oral glutathione was associated with changes in skin properties and oxidative-stress markers, but the study was small and does not prove dramatic transformation for every person 12. Reported risks can include gastrointestinal upset, rash, headache, or reactions related to injection or nasal use. People with asthma, pregnancy, complex liver disease, or multiple medications should be reviewed carefully.

At Chia, glutathione is available as injection from $199/mo and nasal spray after clinician review. Like other compounded medications, it is prepared for an individual patient by a state-licensed 503A pharmacy.

What actually drives your results: dose, form, and consistency?

Results come from the match between the peptide, the dose studied or prescribed, the form, your biology, and your habits. The same peptide can feel very different if side effects limit nutrition, hydration, sleep, or movement.

Injection vs. tablet vs. nasal spray

Many peptides are fragile in the gut, so injection is common. Some compounded treatments may also be offered as tablets or nasal sprays when a pharmacy can prepare them and a clinician decides the form fits the patient. Different forms should not be assumed to have the same absorption or outcomes.

Microdosing and titration

Titration means changing dose over time under medical supervision. The FDA labels for Wegovy and Zepbound use gradual dose escalation to improve tolerability 1, 2. At Chia, microdosing plans are available for compounded semaglutide and compounded tirzepatide when our providers decide that approach fits the patient’s goals and health history.

Diet, sleep, and resistance training

A peptide can support the process, but it does not replace the basics. Higher protein intake, resistance training, sleep, and side-effect management help protect lean mass during weight loss 10. Without these, a before-and-after may show weight loss but also lower strength or poorer nutrition.

Are peptides better than Ozempic?

Ozempic is semaglutide, a GLP-1 receptor agonist FDA-approved for type 2 diabetes, not a general label for all peptides. Some peptides target weight, some target hormone signaling, and others target oxidative-stress biology, so “better” depends on the goal and risk profile.

The fair answer: GLP-1 medicines have the clearest weight-loss before-and-after evidence. Other peptides may fit different goals, but they should not be compared to Ozempic as if they all do the same job.

What peptide does Jennifer Aniston take?

Celebrity peptide claims are usually not medical evidence. Any mention of Jennifer Aniston or other celebrities is based on public reporting, interviews, or social media; Chia does not confirm any individual person’s medication use.

This matters because celebrity “before and after” content leaves out the medical context: diagnosis, BMI, labs, nutrition, side effects, contraindications, dose, duration, and whether the person used a brand medication, a compounded medication, or no medication at all. For weight-loss drugs, FDA labels and randomized trials are stronger sources than public rumor 1, 2, 3, 4.

What is the downside of peptides?

Peptide therapy risks depend on the peptide and the patient. The main downsides are side effects, contraindications, unrealistic expectations, poor-quality sourcing, and using treatment without clinician oversight.

• GLP-1 side effects: nausea, vomiting, diarrhea, constipation, reflux, abdominal pain, gallbladder problems, and rare pancreatitis warnings are listed in semaglutide and tirzepatide labels 1, 2.
• Contraindications and warnings: semaglutide and tirzepatide labels include boxed warnings about thyroid C-cell tumors in rodents and contraindications for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 1, 2.
• Lean-mass loss: weight loss can include muscle as well as fat, so protein intake and resistance training matter during treatment 10.
• Sermorelin risks: headache, flushing, dizziness, nausea, injection-site reactions, and glucose-related concerns may occur, and hormone-sensitive medical histories need clinician review 5.
• NAD+ and glutathione limits: these compounds may affect cellular or oxidative-stress pathways, but results are variable and not guaranteed 8, 9, 11, 12.
• Unlicensed sources: no-prescription “research chemical” vendors can create avoidable risk. A licensed provider and state-licensed 503A pharmacy are the safer path for legitimate prescription care.

BPC-157, TB-500, CJC-1295/ipamorelin, and similar research peptides are often discussed online for tissue repair, recovery, or body composition. These are education-only here unless listed in Chia’s live catalog; Chia does not offer BPC-157, TB-500, CJC-1295, or ipamorelin based on the catalog provided for this article.

How does starting peptide therapy with Chia work?

Chia peptide care starts online. You complete a short health questionnaire, then a licensed US provider reviews your history, goals, medications, and risk factors. If treatment is clinically appropriate, the prescription is sent to a state-licensed 503A compounding pharmacy and shipped to your door.

For weight-loss goals, Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection. Microdosing plans are available for both GLP-1 options when provider-guided dosing is appropriate. A prescription is never guaranteed.

For longevity and body-composition goals, Chia offers sermorelin, NAD+, and glutathione in the forms listed in our catalog. Some patients may discuss multi-treatment options such as Foundation Longevity or GLP-1 + Sermorelin with a provider.

How should you track your own before-and-after safely?

Tracking should show health, not just a smaller number on the scale. Use a simple baseline and repeat it at regular intervals, such as every 4 weeks, so you can see trends without obsessing over daily noise.

1. 1Take baseline weight, waist measurement, blood pressure, resting heart rate, and photos in the same lighting if you choose to use photos.
2. 2Track appetite, nausea, bowel habits, reflux, hydration, and protein intake weekly.
3. 3Track strength markers such as push-ups, squats, walking pace, or gym lifts so weight loss does not come at the cost of function.
4. 4Ask your clinician which labs are appropriate for you. Depending on your history, this may include glucose markers, lipids, liver enzymes, kidney function, thyroid labs, or hormone testing.
5. 5Pause the “before and after” mindset if side effects become severe. Severe abdominal pain, repeated vomiting, dehydration, or signs of allergic reaction need prompt medical care.

Photos can be motivating, but they can also mislead. Lighting, posture, clothing, dehydration, and filters can change the story. A safer goal is a pattern of better health markers and tolerable treatment over time.

Frequently asked questions

Keep reading

Peptides

Peptide Cheat Sheet: Patient Reference to Common Peptides, Uses, and Dosing

Peptides

Peptides Explained: What They Are, How They Work, and Which Ones Are FDA-Approved

Peptides

Peptide Solutions: A Patient's Guide to Therapeutic Peptides